Therapy for cystic fibrosis - The end of the beginning?

New England Journal of Medicine

Volumn 365, Issue 18, 2011, Pages 1734-1735

  Davis, Pamela B ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IVACAFTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLELE; CODON; CYSTIC FIBROSIS; DISEASE COURSE; DRUG MECHANISM; EDITORIAL; FOLLOW UP; GENE MUTATION; HUMAN; LUNG DISEASE; LUNG FUNCTION; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL; SYMPTOM; WEIGHT GAIN;

EID: 80455144623     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1110323     Document Type: Editorial

References (9)

1. Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011;365:1663-72.
2. Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-65. (Pubitemid 19231813)
3. Accurso FJ, Rowe SM, Clancy JP, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010;363:1991-2003.
4. Van Goor F, Hadida S, Grootenhuis PD, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A 2009;106:18825-30.
5. Cheng SH, Gregory RJ, Marshall J, et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827-34. (Pubitemid 120035055)
6. Okiyoneda T, Barrière H, Bagdány M, et al. Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 2010;329:805-10.
7. Ma T, Thiagarajah JR, Yang H, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 2002;110: 1651-8. (Pubitemid 35424243)
8. Chmiel JF, Davis PB. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respir Res 2003;4:8.
9. Drumm ML, Konstan MW, Schluchter MD, et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005; 353:1443-53. (Pubitemid 41400918)